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Abstract
Pregnancy-associated malaria (PAM) is associated with placenta pathology and poor pregnancy outcome but the
mechanisms that control the malaria parasite expansion in pregnancy are still poorly understood and not amenable for
study in human subjects. Here, we used a set of new tools to re-visit an experimental mouse model of pregnancy-induced
malaria recrudescence, BALB/c with chronic Plasmodium berghei infection. During pregnancy 60% of the pre-exposed
primiparous females showed pregnancy-induced malaria recrudescence and we demonstrated that the recrudescent P.
berghei show an unexpected enhancement of the adherence to placenta tissue sections with a marked specificity for CSA.
Furthermore, we showed that the intensity of parasitemia in primigravida was quantitatively correlated with the degree of
thickening of the placental tissue and up-regulation of inflammation-related genes such as IL10. We also confirmed that the
incidence of pregnancy-induced recrudescence, the intensity of the parasitemia peak and the impact on the pregnancy
outcome decreased gradually from the first to the third pregnancy. Interestingly, placenta pathology and fetal impairment
were also observed at low frequency among non-recrudescent females. Together, the data raise the hypothesis that
recrudescent P. berghei displays selected specificity for the placenta tissue enabling on one hand, the triggering of the
pathological process underlying PAM and on the other hand, the induction of PAM protection mechanisms that are
revealed in subsequent pregnancies. Thus, by exploiting P. berghei pregnancy-induced recrudescence, this experimental
system offers a mouse model to study the susceptibility to PAM and the mechanisms of disease protection in multigravida.
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Introduction
It is estimated that more than 50 million pregnancies occur in
malaria endemic areas per year, and approximately half of these
occurinsub-SaharanAfrica,wherePlasmodiumfalciparumtransmission
is most intense [1]. In these regions adults tend to become protected
from severe forms of the disease and from high-density parasitemia.
Such protection appearsto be partially lost during pregnancy when P.
falciparum infection frequently courses with maternal and fetal
morbidity leading to over 100.000 infant deaths in Africa every year
[2]. Besides experiencing the common malaria symptoms, pregnant
women suffer higher abortion rates and their offspring manifest
intrauterinegrowthretardationin combinationwith low birth weight,
which is a known risk factor for neonatal mortality [3,4].
In pregnancy-associated malaria (PAM) the occurrence of
stillbirths, premature and low-birth weight deliveries is attributable
in part to maternal malaria-induced anemia [5], but the risk of low
birth weight approximately doubles if women have placental
malaria [6]. The infection of the placenta is characterized by
accumulation of infected red blood cells (iRBC) in the intervillous
spaces that, together with the concurrent placental pathology,
could lead to fetal development impairment [7]. It has been
proposed that the combined effect of parasite sequestration,
massive intervillous inflammatory infiltration, thickening of the
trophoblastic basement membrane and cytotrophoblast prolifera-
tion may disturb the transport of oxygen and nutrients across the
placenta, impairing the development of the fetus [7].
It is widely accepted that a key component of the severe forms of
P. falciparum malaria is the ability of the iRBC to adhere and be
sequestered in various tissues. This is due to the interaction
between parasite proteins expressed on the iRBC membrane and a
variety of host receptors. In PAM, candidate host receptors for
placental iRBC sequestration include a glycosaminoglycan, the
low-sulphated chondroitin sulphate A (CSA) [8], which is spread
throughout the intervillous spaces [9,10]. Furthermore, it was
shown that the gene var2csa is highly expressed in placental
parasites [11] and confers enhanced CSA adhesion and specific
antigenic properties to the iRBC [12]. These distinct antigens
expressed by placental P. falciparum are considered major targets
for acquired protective immunity to PAM [13,14].
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acquired immunity to placental P. falciparum is an effective
protection mechanism in PAM [15]. Thus, in areas of high
malaria transmission, it has been repeatedly observed that the risk
of PAM decreases in multigravida. The severe clinical manifes-
tations are mainly restricted to the first and second pregnancies
[16], when the levels of specific antibodies against placental
parasite antigens are not high enough to confer protection [17,18].
Interestingly, in areas of infrequent malaria exposure, where
women have little or no malaria immunity, the disease results in
severe outcomes both for the mother and the baby, irrespective of
parity [9], reinforcing the notion that the severity of clinical
manifestations during pregnancy depends on pre-existing immu-
nity of the mother [19]. Thus, malaria exposure through
consecutive pregnancies is required for placental malaria immu-
nity to develop and be maintained [15].
Nevertheless, in high transmission areas women that are
exposed to malaria before pregnancy may show increased
susceptibility to malaria during pregnancy but the parasite and
host mechanisms that lead to parasite recrudescence are difficult to
address in human populations. In addition, malaria can be
asymptomatic during pregnancy and have serious consequences
for the developing fetus [9,20] suggesting that complex pathogen-
esis mechanisms are linking parasite recrudescence, placenta
pathology and pregnancy outcome. Moreover, the biological basis
of the protection acquired by multigravida needs to be investigated
in experimental systems that warrant absence of re-infection.
In the 1980 s, van Zon and Eling provided seminal descriptions
of pregnancy-induced malaria recrudescence in mice [20,21] and
noted higher vulnerability to malaria in pregnant female mice.
Recently, we have shown that the main pathological features of
severe PAM are reproduced in a mouse model [22] and
Megnekou et al. [23] evidenced that pregnant mice accumulated
specific antibodies against recrudescent parasite. These reports
point to the value of mouse models as a research tool in pregnancy
malaria. Here we extended our studies on experimental PAM and
investigated whether pregnancy-induced P. berghei ANKA recru-
descence correlated with placenta pathology, decreased with parity
and was associated with enhanced binding of the recrudescent
parasite to placental tissue.
Materials and Methods
Animals, parasites and infection
BALB/c mice were bred and maintained in conventional
housing and fed with regular diet. All procedures were in
accordance with national regulations on animal experimentation
and welfare, authorized by the Instituto Gulbenkian de Cie ˆncia
animal welfare committee. Infection experiments were performed
in adult females, between 10–15 weeks of age. P. berghei ANKA
constitutively expressing green fluorescent protein (P. berghei
ANKA-GFP) (259Cl2 clone) [24,25]. The mice were infected
intra-peritoneally (IP) with 10
6 iRBC obtained from frozen stocks
and treated IP with 0.7 mg chloroquine for 3 days, starting at day
7 post-infection [26] and parasitemia was recorded every other
day using flow cytometry analysis as described elsewhere [27]. Five
to ten percent of the female mice exposed to this treatment
succumbed but the remaining recovered from the infection after
chloroquine therapy and were used in pregnancy-induced
recrudescence experiments.
Parasite recrudescence and offspring monitoring
Forty days post-infection a group of treated females were put to
mate and the remaining were used as non-pregnant controls.
Detection of the vaginal plug and measurement of body weight
were jointly used to time gestation, as previously described [28].
The day of vaginal plug detection was considered as gestational
day one (G1). Pregnancy was confirmed between G10 and G13
when the animals had an average increase of 3–4 g in body
weight. Thus, weight gain was taken as sign of pregnancy and
sudden weight loss as an indicator of pregnancy injury or
interruption. Some of the pregnant females were subjected to
caesarian section at G19 for placenta pathology studies, while the
others were allowed to deliver and to follow to subsequent
pregnancies. At delivery, the weight and the number of live
newborns were registered. Newborns weight and development was
followed up to day 30 after birth. Non-infected pregnant females
were used as controls.
Placentas collection and histopathological analysis
Females were killed by CO2 narcosis at G19. Placentas from
infected and non-infected pregnant females weretreated in a similar
way. Placentas were separated in two halves, one half was frozen for
RNA extraction and the other was fixed in 10% formalin for further
processing. Paraffin-embedded non-consecutive placenta sections
were stained with hematoxylin-eosin (HE) and examined in light
microscopy (Leica DM LB2, Leica Microsystems). For histological
and morphometric analysis, placental sections were blindly
examined as previously described [22].
Gene-Specific Expression by qRT-PCR
Total RNA, from individual placentas and viable newborns, was
obtained using an RNeasy Mini Kit (Qiagen), following the
manufacturer’s protocol for animal tissues. One microgram of total
RNA was converted to cDNA (Transcriptor First Strand cDNA
Synthesis Kit, Roche) using random hexamer primers. MCP-1
(Ccl2) and MIP-1a (Ccl3) expression was quantified using TaqMan
Gene Expression Assays from ABI (Mm00441242_m1 and
Mm00441258_m1, respectively) with TaqMan Universal PCR
master mix. T lymphocytes (Cd3e), natural killer cells (Klrd1),
macrophages (Mgl2), neutrophils (Ncf2), cytokines and hemoxygen-
ase-1 (Hmox-1) expression was amplified using primer sequences
previously described [29]. Endothelin-1 (Edn1)a n db-actin (Actb)
specific primer sequences were, Edn1 -59-ACG CAC AAC CGA
GCA CAT TGA CTA C-39and 59 TCC TGC CCG TCT GAA
CAA GAA ACT G-39 and Actb -5 9 AGC CAT GTA CGT AGC
CAT CC-39 and 59-CTC TCA GCT GTG GTG GTG AA-39.
These qRT-PCR reactions used Applied Biosystems Power SYBR
Green PCR Master Mix. The gene expression quantification
reactions were performed according to the manufacturers’ instruc-
tions on an ABI Prism 7900HT system. Relative quantification of
specific mRNA was normalized for a mouse housekeeping gene
mRNA. To select an appropriate internal control, we studied the
expression of the following housekeeping genes: ACTB, GAPDH,
TATA box binding protein (TBP), Succcinate dehydrogenase
complex, subunit A (SDHA) and Tyrosine 3-monooxygenase/
tryptophan 5-monooxygenase activation protein, zeta polypeptide
(YWHAZ). The last three genes have been previously validated in
human placental malaria [30]. Due to uneven gene expression,
when comparing non-infected and infected placentas, the house-
keeping genes TBP, SDHA and YWHAZ were unsuitable for
internal controls. Conversely, ACTB and GAPDH expression was
maintained under infection conditions.
Synchronization of parasitized erythrocytes
Infected red blood cells were obtained from infected non-
pregnant mice, and from pregnant females with recrudescence,
having 10–20% parasitemia. In order to obtain mature blood
Pregnancy-Recrudescent Malaria
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GFP infected erythrocytes were synchronized as described
elsewhere [31]. Usually, the mature forms enrichment yields over
90% of infected cells. The enriched infected erythrocytes
preparations were suspended in PBS at a concentration of 10
8
iRBC/ml.
iRBC binding assays in placental sections
Placentas from uninfected BALB/c females, obtained at G19,
were treated using a previously described protocol [10]. Briefly,
the placentas were fixed in 2% formalin and 0.5% glutaraldehyde
for 10 minutes, heated in a microwave oven before being paraffin-
embedded, cut into sections of 5 mm onto glass slides and then
deparafinized and rehydrated. This fixation protocol aims to
preserve the binding capacity of glycosaminoglycans in the
placenta intervillous spaces. For placenta-receptor cleavage
experiments, placental sections were incubated with 0.5 U/ml
chondroitinase ABC (from Proteus vulgaris, Sigma) or heparinase II
(from Flavobacterium heparinum, Sigma) as a negative control, or with
PBS, for 2 periods of 2 hours at 37uC. Fifty microliters of
synchronized iRBC suspension were overlaid onto each tissue
section for 60 minutes at 37uC in a humid chamber. For iRBC-
ligand blocking experiments, synchronized iRBC were preincu-
bated, for 30 minutes at 37uC, with CSA from bovine trachea
(Sigma) or colominic acid sodium salt (CA) from E. coli (Sigma) as
negative control, using the concentration of 1 mg/ml for each.
This concentration was chosen to achieve maximum binding
inhibition, while lower concentrations such as 100 mg/ml led to
about 50% inhibition of specific binding (data not shown). The
slides were mounted with Mowiol and examined under fluores-
cence microscopy at 406 magnification. The number of
fluorescent green fluorescent iRBC adhering placenta sections in
each experimental condition was determined in a blind fashion
and counting for each section 50 microscopic fields.
Statistical analysis
Statistical differences between groups of mice were evaluated by
the Student-t or Mann-Whitney tests. Chi-square or Pearson tests
were used for association or correlation analysis, respectively.
Results
Pregnancy-induced malaria recrudescence and poor
pregnancy outcome
A total of one hundred female mice were infected with P. berghei-
parasitized red blood cells and subsequently treated with
chloroquine, typically showing a transient parasitemia peak, which
eventually resolved. In absence of pregnancy, parasitemia
remained essentially subpatent and was not observed thereafter
(Figure 1A). In contrast, parasite recrudescence was frequently
observed when malaria-treated females become pregnant
(Figure 1A), more often after gestation day 14 (G14) but never
before G12. We followed the first pregnancy of eighty-four pre-
exposed females and found out that forty nine (58%) showed
parasite recrudescence induced by pregnancy. Twenty-nine
recrudescent females were followed to the end of pregnancy and
we observed uncontrolled parasitemia leading to severe malaria
and eventually to maternal death in nine of those females (31%)
while the remaining controlled the parasitemia peak and were
apparently cured. These results confirm the hypothesis that
subpatent P. berghei infection is exacerbated by pregnancy.
To evaluate the effect of pregnancy-induced malaria recrudes-
cence in the pregnancy outcome we monitored the offspring of
primiparous recrudescent females (Figure 1B). The twenty-nine
recrudescent mothers had significantly smaller litter sizes (average
of 1.9 newborns/litter) as compared to twenty non-infected
females (5.9 newborns/litter in average). Likewise, the average
birth weight of newborns from recrudescent mothers (1.1 g) was
significantly lower when compared to the newborns from non-
infected mothers (1.4 g). These findings indicate that recrudescent
females show poor pregnancy outcome that is characterized by
decreased fetal viability and intra-uterine growth retardation.
Parasitemia recrudescence correlates with placenta
pathology
The poor pregnancy outcome in females infected during
pregnancy is associated with a placental inflammatory response
that leads to marked tissue disorganization [22], and the presence
of maternal iRBC of different stages of maturation in the placenta.
In recrudescent primiparous females the intensity of peripheral
parasitemia was quantitatively correlated with the reduction of the
placental vascular spaces (P-value=0.0012) (Figure 2A). In
particular, recrudescent females with high parasitemia showed
increased reduction of vascular spaces. These results strongly
suggest that malaria recrudescence correlated with placental tissue
damage (Figure 2C and D) that possibly underlies the observed
poor pregnancy outcomes. Furthermore, the expression analysis of
cell-type specific genes in placentas from females with recrudes-
cence, revealed increased amounts of inflammatory cells, partic-
ularly natural killer (NK) cells, T cells and macrophages
(Figure 3A) and up-regulation of macrophages attractant chemo-
kines (MCP-1 and MIP1-a) (Figure 3B).
We also found that the expression of several molecules related to
vascular stress, namely hemoxygenase-1 (HO-1) and endothelin-1
(ET-1), was increased in placentas of recrudescent females
(Figure 3D). TNF-a expression showed a trend to increase in
infected placentas and the balance of the immuno-modulatory
molecules IL-12 and IL-10 expression denoted an anti-inflamma-
tory response in the course of the placenta malaria pathogenesis
(Figure 3C). In fact, IL-10 expression was particularly increased in
placentas where pathology was more intense (Figure 3E).
Enhanced adhesion of recrudescent P. berghei - GFP
iRBC sequestration appears to be the pathogenic trigger of the
placenta pathology observed in pregnant women and we have
previously shown that P. berghei iRBC specifically adhere to the
mouse placenta tissue. To evaluate the adhesion properties of the
recrudescent P. berghei we performed adhesion assays on placental
sections that compared the adhesion properties of iRBC collected
from recrudescent primiparous females with iRBC isolated from
infected males and non-pregnant females. Strikingly, the amount
of iRBC adhering to the placenta sections was four-fold increased
in the samples from recrudescent primiparous females (Figure 4A).
The adhesion of the recrudescent parasite was partially inhibited
when the placental sections were treated with chondroitinase
(70%), and also when the iRBC were pre-incubated with CSA
(56%) (Figure 4B). These results indicate that CSA is involved in
the adhesion of the recrudescent parasite to the placenta tissue and
suggest that the recrudescent P. berghei expanding during
pregnancy displays enhanced specificity to the placenta and
consequently may induce a specific host response to the
pregnancy-associated parasite.
Pregnancy-induced recrudescence and disease severity
are reduced in multiparity
To test whether pregnant females were able to mount a response
upon exposure to the recrudescent parasite, we followed up the fate
Pregnancy-Recrudescent Malaria
PLoS ONE | www.plosone.org 3 May 2009 | Volume 4 | Issue 5 | e5630Figure1.Malaria susceptibilityis increased duringpregnancywith detrimentaleffectsfor the progeny.Representative parasitemiacurves
of BALB/c females infected with P. berghei - GFP (day 0) and treated with chloroquine for 3 days starting at day 7 (Panel A). Parasitemias of females
maintained without male (non-pregnants) are represented in the upper plot. The lower plot shows 5 typical parasitemia curves of recrudescent
primigravida. In Panel B average litter sizeandbirth weight of 20 litters from non-infected primiparous females are compared with the average litter size
of 29 litters and the birth weight average of 6 litters, from recrudescent primiparous females. Error bars represent standard error (***, p,0.001).
doi:10.1371/journal.pone.0005630.g001
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pregnancy-induced peripheral parasitemia peak was graded as high
recrudescence, if higher than 5%, and as patency, if between 1%
and 5%, while the pregnant females with less than 1% of iRBC as
detected by FACS analysis were declared non-recrudescent. We
found that the aggregate incidence of high recrudescence and
patency significantly decays from the first (59%) to the second (41%)
and third pregnancy (22%) (Figure 5A). The reduced incidence of
cases with high pregnancy parasitemia peaks (more than 5% of
iRBC) was particularly striking and close to a four-fold reduction
from the first (44%) to the second pregnancy (12%). Accordingly,
the level of parasitemiaalso decreased significantly when comparing
first (14.5%619.2%), second (3.9%69.4%) and third pregnancy
(2.0%64.1%) (Figure 5B).Also, the littersizeandthenewborn birth
weight were lower in the first pregnancy but recovered and
approximated normal levels in subsequent pregnancies (Figure 6).
Furthermore, analysis focused on recrudescent females revealed
that maternal mortality associated to recrudescence decreases with
parity (Table 1) suggesting a decrease in disease severity. These
results suggest that females that are repeatedly exposed to
recrudescent parasites during pregnancy develop a protective
response that tends to control parasite recrudescence and placental
malaria during subsequent pregnancies.
PAM protection in multigravida is not attributable to the age of
the pregnant females as we observed that pregnancy-induced
recrudescence incidence in primigravida was not reduced at older
ages. In particular, females infected under 20 weeks of age
presented about 55% of recrudescence and in the group of older
females, with more than 20 weeks, the recrudescence was about
65%. Furthermore, pregnancy-induced recrudescence seems to be
uncorrelated with the period between infection and the first
pregnancy, since we were able to observe recrudescence 40 weeks
after infection. These data suggest that both the age of the mother
and the duration of subpatent parasitemia are not determining
factors in triggering parasite recrudescence.
It is worth noting that, regardless the number of previous
pregnancies, the placentas from recrudescent females typically
showed iRBC in the maternal blood spaces, inflammatory
Figure 2. Peripheral parasitemia correlates with the reduction of placental blood sinusoids area. (A) The blood sinusoidal area is plotted
against the peripheral parasitemia peak observed in the pregnancy of primiparous females. The area of placental blood sinusoids, expressed as a
fraction of the total placental area, was obtained using an automated morphometric procedure as described in Materials and Methods section. In
recrudescent females, the degree of parasitemia was correlated with sinusoidal area reduction (correlation coefficient for recrudescent females is
0.45, P-value=0.0012). Representative photomicrograph of placental sections HE stained from non-infected (B) and recrudescent (C–D) mothers.
Accumulation of inflammatory cells (C), trophoblast thickening (arrows) and presence of iRBC (D) in blood sinusoids (arrowheads) are evidenced in
placenta tissue from recrudescent mothers. Scale bars represent 15 mm in (B–D).
doi:10.1371/journal.pone.0005630.g002
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architecture disruption and trophoblast basal membrane thicken-
ing (data not shown). We noted that among non-recrudescent
females the litter size was below normal levels and that irrespective
of parity, about ten percent died during pregnancy or shortly after
delivery (Table 2). The analysis of non-recrudescent placentas in
some cases revealed the presence of iRBC and tissue lesions
resembling the pathology observed in recrudescent females
(Figure 7). These data suggest that albeit at low frequency,
placental malaria occurs in absence of peripheral parasitemia
recrudescence. Together, this study suggest that pregnancy-
associated malaria evoked by recrudescent P. berghei is attributable
to parasites with enhanced specificity for the placental tissue that
are able to induce an inflammatory response during pregnancy
and a cumulative protective response in multigravida that had
experienced recrudescences induced by pregnancy
Discussion
In this paper we analyzed a mouse model of pregnancy-induced
malaria recrudescence in which the intensity of parasite recrudes-
cence showed to be quantitatively correlated with the placenta
pathology and the recrudescence incidence decreased with parity.
Furthermore, we showed that the recrudescent parasite displays
enhanced adhesion to the placenta suggesting that P. berghei could
be helpful in investigating and clarifying the intricate mechanisms
governing the increased risk of malaria recrudescence induced by
pregnancy [34,35].
Our experiments in mice clearly support the possibility that
PAM in pre-exposed individuals does not require re-infection and
suggest that malaria recrudescence during pregnancy can be
caused by pregnancy-specific mechanisms that remain to be
identified. These results are well in line with early findings by van
Zon and Eling [20,32] and more recently by Megnekou et al. [23]
reporting P. berghei peripheral recrudescence in pregnant female
mice that acquired the infection before conception. Moreover, in
our analysis parasite recrudescence was never detected before
gestation day 12 (G12), and most frequently parasitemia arose
after G14. Placental development studies show that at G10.5
maternal blood starts to be evident in the labyrinth but only by
G12.5 the definitive placenta becomes functional [38]. These
observations converge to the notion that the placenta plays a
critical role in development of murine PAM, possibly by
promoting parasite recrudescence.
One of the currently proposed roles for the placenta in PAM
pathogenesis is to provide new ligands that are recognized by the
iRBC. We have previously shown that P. berghei binds CSA and
hyaluronic acid [22] and in this study we demonstrated that iRBC
collected from recrudescent females displayed a marked enhance-
ment of CSA binding properties. The role of hyaluronic acid in the
iRBC-placenta interaction has been to a certain extent contro-
versial [33–35], but we observed that hyaluronidase and pre-
incubation with hyaluronic acid inhibit the binding of recrudes-
cence iRBCs to the placenta (data not shown). The adhesion
assays clearly indicate that recrudescent P. berghei iRBC have
higher ability to adhere to the placenta, raising the hypothesis that
Figure 3. Placenta pathology is associated with altered gene expression of inflammation markers. qRT-PCR of placenta tissue was used
to detect the expression of cell type–specific genes indicating infiltration of inflammatory cells: Klrd1 gene for Natural Killer cells, Cd3e gene for T cells,
Ncf2 gene for neutrophils and Mgl2 for macrophages (A). Placental gene expression was quantified for relevant markers of monocyte/macrophage
chemotaxy (B), inflammation mediators (C) and vascular stress (D). RNA expression was quantified in 15 placentas from recrudescent primiparous
BALB/c females and in 8 uninfected placentas, collected on G19. In (E) placental IL10 mRNA expression was separately analyzed in 5 placentas
showing moderate pathology (+) and 4 placentas showing severe (++) pathology. Relative quantification was obtained with normalization by b-actin
for (A), (C), (D) and (E) and by GAPDH for (B). Results are plotted as fold change over the respective non-infected controls and each bar represents the
mean6s.e.m. (*, P-value,0.05).
doi:10.1371/journal.pone.0005630.g003
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to bind placental ligands. This hypothesis is supported by very
recent work showing that pregnant mice acquire immunity specific
to the recrudescent parasite [23]. This would parallel previous
reasoning suggesting that in human PAM specific P. falciparum
variants, such as the variant expressing the PfEMP1 molecule
encoded by the var gene var2csa, are expanded via the increased
cytoadherence of the iRBC to the placental receptors, prominently
the CSA [39]. It is noteworthy that P. berghei variant antigens were
not described so far, even though antigenic variation had been
shown in other murine malaria species, such as P. chabaudi AS
[36,37]. Nevertheless, our data opens the possibility that murine
PAM entails an overrepresentation of P. berghei - iRBC displaying
parasite components that mediate the iRBC-placenta interactions.
Thus, this model provides an opportunity to study the molecular
Figure 4. P. berghei iRBC from recrudescent females show
enhanced adhesion to placenta. iRBC from males, non-pregnant
females and recrudescent primiparous females were incubated on
uninfected placental sections and the adherent parasitized cells were
counted as described in Materials and Methods section (A). Adhesion
assays were also performed after pre-treatment of placental sections
with chondroitinase ABC or heparinase (negative control) (B, upper
plot). Adhesion inhibition assays were carried out by pre-incubating
iRBC from recrudescent females with 1 mg/ml concentrations of CSA or
CA (negative control) (B, lower plot). In panel B the proportion of bound
iRBC is expressed as a percentage of the control (non-treated placentas
or non-preincubated iRBC, in upper and lower plots, respectively). Error
bars represent the mean6s.e.m. of three independent experiments.
(***, P-value,0.001).
doi:10.1371/journal.pone.0005630.g004
Figure 5. Recrudescence incidence and peripheral parasitemia
are decreased in multigravida. (A) Frequency of females with high
recrudescence (above 5% parasitemia), patency (parasitemia between
1% and 5%) and no recrudescence (parasitemia ,1%) according to
parity. Recrudescence incidence is significantly associated with parity
(P-value=0.001, Chi-square test). (B) Box-plots illustrate the range of the
peripheral parasitemia peak according to parity. The parasitemia peak
in the first pregnancy was significantly different from the second (P-
value=0.004) and third pregnancies (P-value=0.006). * and
# represent
extremes and outliers, respectively.
doi:10.1371/journal.pone.0005630.g005
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parasites also observed in human PAM.
In the course of P. falciparum infections, the placenta can harbor
a striking density of parasites, macrophages, haemozoin and excess
of fibrinoid deposits associated to morphologic alterations, such as
syncytiotrophoblast necrosis and trophoblast basement membrane
thickening [38] that would be harmful to the developing fetus, as
the placental exchanges of respiratory gases and nutrients became
difficult and reduced. We previously demonstrated that these
characteristics can also be observed in the model system using
BALB/c mice and P. berghei ANKA [22]. A remarkable
pathological finding in P. berghei ANKA recrudescent placentas
was the reduction of blood sinusoids space that is attributable to
placental tissue thickening (Figure 2D). In addition, we showed
that the reduction of the blood sinusoidal space is highly
dependent on the parasitemia level (Figure 2A), reinforcing the
notion that the parasite has a pivotal role in the genesis of the
placental pathology.
Cytoadherence of P. berghei–infected erythrocytes to receptors
expressed on the syncytiotrophoblast surface is considered to
contribute to the described placental disorders, but it is not a
sufficient condition for pathogenesis [39]. Placental malaria studies
propose that the observed intervillositis is mostly an immunopath-
ologic process, due to cytokines and chemokines production and
leading to the activation of the syncytiotrophoblast [40,41].
Monocytic/macrophagic infiltrate has been considered a
hallmark of Plasmodium-infected placentas [39,42,43]. We had
previously verified that infected P. berghei-GFP mouse placentas
had an accumulation of mononuclear cells [22]. It is important to
remark that in mouse placentas we observed low degree of massive
chronic intervillositis as compared to reported observations in
infected human placentas [44]. Possibly this difference is related to
the short pregnancy time span that may condition the inflamma-
tory process in the mouse as compared to human pregnancy. The
expression profile of inflammatory genes suggests that, at the end
of the pregnancy period, the placentas of recrudescent mice
undergo a strong inflammatory process. This is inferred from the
significant increase of cell-type specific markers for NK cells, T
lymphocytes and macrophages as well as increased expression of
chemoattractant factors (Figure 3A and B). Our results are in
accordance with a recent study in Kenya showing NK and T cell
infiltration in P. falciparum-infected human placentas [45]. It
remains to be resolved whether T cell infiltration corresponds to
activated effector T cells or to T regulatory cells as part of a
placenta anti-inflammatory response. Interestingly, in our model,
IL-12 expression in the placenta was significantly decreased
(Figure 3C), while the expression of TNF alpha and IL-10 was
increased. This down-regulation of IL-12 production, presumably
from its main cell sources was suggested to be due to the inhibitory
effects of hemozoin [46]. These observations allow the speculation
Figure 6. Reduced adverse pregnancy outcomes in multigrav-
ida. Box-plots of the average litter size (A) and average newborn birth
weight (B) according to parity (first, second and third pregnancy).
Pregnancy outcome was significantly different in primigravida as
compared to multigravida and non-infected pregnant females (***, P-
value,0.001; **, P-value,0.01; *, P-value,0.05).
doi:10.1371/journal.pone.0005630.g006
Table 1. Disease severity and pregnancy outcome in P. berghei recrudescent females according to parity.
Parity
Pregnant
females
Average
parasitemia peak (%)
Maternal
mortality (%) Litter size
a
Newborns Birth
weight (g)
a
Primigravida 29 22.7 31 1.963.0 (29) 1.160.2 (6)
Second Pregnancy 9 10.7 20 5.662.1 (9) 1.360.2 (7)
Third Pregnancy 3 3.4 0 6.761.2 (3) 1.360.1 (3)
Non-Infected 20 ___ 0 5.962.2 (20) 1.460.2 (20)
aMean6stdev (number of litters analyzed).
doi:10.1371/journal.pone.0005630.t001
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iRBC adhesion is counteracted by a systemic anti-inflammatory
response. In fact, we noted that the up-regulation of IL10
expression was correlated with the severity of placenta pathology
(Figure 3E). Coincidently, IL-10 levels in the serum have been
associated with poor pregnancy outcomes and was suggested as a
biomarker for placenta inflammation in pregnant women [47].
Placenta microcirculation is in part controlled through a fine
balance between different vasoconstrictors such as ET-1, and
vasodilators, namely nitric oxide or HO-1 enzyme [48,49].
Recrudescent placentas showed increased ET-1 and HO-1 mRNA
expression, suggesting that the placenta vasculature is exposed to
abnormal vasoactive regulation. Interestingly, we found that in
some non-recrudescent females, the placentas could harbor a very
low density of iRBC, which nevertheless seemed high enough to
trigger placenta pathology (Figure 7). We speculate that these
pathologic mechanisms would explain the death of pregnant
females that do not show peripheral parasitemia but exhibit
placental pathology.
There is solid epidemiological evidence from high-endemicity
malaria regions that the incidence of PAM in women is parity-
dependent[1].In mice, reduced recrudescence has been observed in
multigravidaafter anti-malaria treatments duringthe first pregnancy
[36]. In the PAM mouse model described here we have also found
that the disease incidence and severity decreased with parity.
Nevertheless, we did not find a correlation between the intensity of
the parasitemia peak in the pre-mating period and the occurrence of
pregnancy-induced recrudescence in the first pregnancy, implying
that such exposure did not confer PAM protection. These
observations compelled us to hypothesize that PAM protection is
acquired through repeated exposure to the recrudescent parasite on
line with a recent report on accumulation of immunity to PAM over
several pregnancies and recrudescences [24]. In this context, a
possible extension of this model could be the repeated pre-exposure
of females before pregnancy. This could help to evaluate the
robustness of protection conferred by non-pregnant parasites.
Here, we report on the analysis of a mouse model of pregnancy-
induced parasite recrudescence that displayed features resembling
those of PAM in women living in high-endemicity regions. This
work further supports the notion that this mouse model may
become a helpful tool to dissect the molecular and cellular
components involved in parasite recrudescence during pregnancy
and to identify the details of the immunological mechanisms
conferring PAM protection.
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Figure 7. Occasional placenta pathology in non-recrudescent pregnant females. Photomicrographs of HE-stained placental sections of
sporadic cases of placental pathology in non-recrudescent females. The figure shows presence of iRBC adhered to the syncytiotrophoblast layer (A,
insert) and in blood sinusoids (arrowheads) as well as trophoblast thickening (arrow). Scale bar represents 15 mm.
doi:10.1371/journal.pone.0005630.g007
Table 2. Disease severity and pregnancy outcome in non-recrudescent females according to parity.
Parity Pregnant females Maternal mortality (%) Litter size
a Newborns Birth weight (g)
a
Primigravida 22 12 3.263.3 (22) 1.460.2 (2)
Second Pregnancy 10 11 3.862.4 (10) 1.460.3 (4)
Third Pregnancy 13 8 3.560.2 (13) 1.560.7 (6)
Non-Infected 20 0 5.962.2 (20) 1.460.2 (20)
aMean6stdev (number of litters analyzed).
doi:10.1371/journal.pone.0005630.t002
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